PDIA2 and breast cancer: Over-expression of PDI may therefore serve as a diagnostic marker for cancer, as suggested for glial cell cancer (Goplen et al., 2006), colorectal cancer (Ataman-Onal et al., 2013), and breast cancer (Thongwatchara et al., 2011).